Ranitidine as an alcohol dehydrogenase inhibitor in acute methanol toxicity in rats.
Methanol poisoning is a hazardous intoxication characterized by visual impairment and formic acidemia. The therapy for methanol poisoning is alcohol dehydrogenase (ADH) inhibitors to prevent formate accumulation. Ranitidine has been considered to be an inhibitor of both gastric alcohol and hepatic aldehyde dehydrogenase enzymes. This study aimed at testing ranitidine as an antidote for methanol acute toxicity and comparing it with ethanol and 4-methyl pyrazole (4-MP). This study was conducted on 48 Sprague-Dawley rats, divided into 6 groups, with 8 rats in each group (one negative control group [C1], two positive control groups [C2, C3] and three test groups [1, 2 and 3]). C2, C3 and all test groups were exposed to nitrous oxide by inhalation, then, C3 group was given methanol (3 g/kg orally). The three test groups 1, 2 and 3 were given ethanol (0.5 g/kg orally), 4-MP (15 mg/kg intraperitoneally) and ranitidine (30 mg/kg intraperitoneally), respectively, 4 hours after giving methanol. Rats were sacrificed and heparinized, cardiac blood samples were collected for blood pH and bicarbonate. Non-heparinized blood samples were collected for formate levels by high performance liquid chromatography. Eye balls were enucleated for histological examination of the retina. Ranitidine corrected metabolic acidosis (p = .025), decreased formate levels (p = .014) and improved the histological findings in the retina induced by acute methanol toxicity.
El-Bakary
Amal A
AA
Department of Forensic Medicine, Histology and Cytology, Faculty of Medicine, Mansoura University, Egypt.
El-Dakrory
Sahar A
SA
Attalla
Sohayla M
SM
Hasanein
Nawal A
NA
Malek
Hala A
HA
D000138:Acidosis / Q000139:chemically induced / Q000517:prevention & control*; D000426:Alcohol Dehydrogenase / Q000037:antagonists & inhibitors*; D000818:Animals; D000931:Antidotes / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D000431:Ethanol / Q000494:pharmacology; D000077604:Fomepizole; D005561:Formates / Q000097:blood; D008297:Male; D000432:Methanol / Q000378:metabolism / Q000506:poisoning / Q000633:toxicity*; D020419:Photoreceptor Cells, Vertebrate / Q000187:drug effects / Q000473:pathology; D011720:Pyrazoles / Q000494:pharmacology; D011897:Random Allocation; D011899:Ranitidine / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012160:Retina / Q000187:drug effects / Q000473:pathology; D012164:Retinal Diseases / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*
D000931:Antidotes; D004791:Enzyme Inhibitors; D005561:Formates; D011720:Pyrazoles; D000431:Ethanol; D000077604:Fomepizole; D011899:Ranitidine; D000426:Alcohol Dehydrogenase; D000432:Methanol